CAPTRUST Financial Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,068
Closed -$252K 2495
2023
Q4
$252K Sell
13,068
-195
-1% -$3.53K ﹤0.01% 2224
2023
Q3
$214K Buy
13,263
+94
+0.7% +$1.67K ﹤0.01% 2244
2023
Q2
$251K Buy
13,169
+129
+1% +$2.3K ﹤0.01% 2109
2023
Q1
$190K Buy
13,040
+39
+0.3% +$699 ﹤0.01% 2065
2022
Q4
$254K Buy
13,001
+1,266
+11% +$24.7K ﹤0.01% 1784
2022
Q3
$283K Buy
11,735
+271
+2% +$8.35K ﹤0.01% 1591
2022
Q2
$361K Sell
11,464
-811
-7% -$29.4K ﹤0.01% 1314
2022
Q1
$540K Buy
12,275
+1,890
+18% +$81.2K ﹤0.01% 1114
2021
Q4
$452K Buy
10,385
+346
+3% +$13.6K ﹤0.01% 1171
2021
Q3
$314K Sell
10,039
-269
-3% -$10.6K ﹤0.01% 1271
2021
Q2
$436K Buy
10,308
+166
+2% +$6.46K ﹤0.01% 1046
2021
Q1
$381K Buy
10,142
+10,002
+7,144% +$313K ﹤0.01% 1089
2020
Q4
$4K Buy
+140
New +$3.6K ﹤0.01% 2927
2018
Q3
Sell
-9
Closed 1661
2018
Q2
$0 Buy
+9
New +$146 ﹤0.01% 1578

Other funds holding ACH

CAPTRUST Financial Advisors's ACH Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Accendra Health (ACH) in Q1 2024, closing a stake of 13,068 shares — an estimated $252K sold.

CAPTRUST Financial Advisors first reported a position in ACH in Q2 2018 and held it in 14 quarters. The position peaked at $540K in Q1 2022. 231 funds tracked by Wall St. Rank hold ACH as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Accendra Health position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 13,068 Accendra Health shares in Q1 2024, an estimated $252K.
  • CAPTRUST Financial Advisors first reported a position in Accendra Health in Q2 2018 and held it in 14 quarters.
  • CAPTRUST Financial Advisors's Accendra Health position peaked at $540K in Q1 2022.
  • 231 funds tracked by Wall St. Rank held Accendra Health as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.